Press release
Biologics Market Outlook Highlighting Key Trends in Oncology Immunological and Cardiovascular Applications Through 2031
Biologics Market
The Global Biologics Market is estimated to reach over USD 718.97 billion by 2031, exhibiting a CAGR of 7.50% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1729
A biologic drug refers to a therapeutic product derived from or composed of components of living organisms. These products encompass a wide range of substances, including recombinant proteins, tissues, allergens, genes, cells, blood components, and vaccines. Biologic therapies are employed in the treatment of various medical conditions, such as anemia, hemophilia, chronic migraines, hepatitis B, rheumatoid arthritis, inflammatory bowel disease, and numerous other diseases and infections.
The growth of the biologics market is being propelled by several key factors, including supportive government initiatives, the increasing market share of biologic therapies, and the rising preference for biopharmaceuticals over traditional chemically synthesized drugs. Furthermore, ongoing advancements in biotechnology have significantly contributed to the success and widespread adoption of biologics.
The market is also benefiting from increased investments, strategic partnerships, and government-backed research and development programs. Innovations in antibody-drug conjugates, immunotherapies, as well as cell and gene therapies, are expected to further accelerate the expansion of the biologics sector throughout the forecast period.
List of Prominent Players in the Biologics Market:
• Abbvie Inc.
• Amgen
• AstraZeneca
• Bayer AG
• Celltrion Inc.
• Addgene
• Eli Lilly & Company
• F. Hoffmann-La Roche Ltd
• GSK group of companies
• Johnson & Johnson Services, Inc
• Merck & Co. Inc
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Precision Biologics, Inc.
• Samsung Biologics
• Sanofi
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Market Dynamics
Drivers:
The increasing prevalence and diagnosis of chronic illnesses have significantly contributed to the demand for advanced diagnostic tools and effective therapeutic solutions, thereby driving growth in the global biologics market. Biologic therapies are genetically engineered medications designed to target specific components of the immune system responsible for inflammation. In response to the global outbreak of COVID-19, governments have taken proactive measures to strengthen healthcare systems and ensure consistent access to biologic treatments. Furthermore, researchers and industry experts are actively exploring various species and expression systems to enhance the efficiency and scalability of biologics production.
Challenges:
Despite their effectiveness, certain biologic therapies have been associated with unintended effects on immune function, leading to an increased risk of severe or opportunistic infections. Patients undergoing treatments that suppress specific immune system responses are particularly vulnerable. These safety concerns may hinder the widespread adoption of biologic therapies, potentially affecting market growth and revenue generation.
Regional Trends:
North America is expected to dominate the biologics market in terms of revenue and is projected to experience robust growth in the coming years. This trend is driven by the presence of a large number of biotechnology and pharmaceutical companies, an increasing incidence of chronic diseases, and strong industry infrastructure. In Europe, market growth is anticipated to accelerate due to collaborative efforts by regulatory authorities, policymakers, and pharmaceutical stakeholders aimed at improving the accessibility and affordability of biologics, particularly monoclonal antibodies (mAbs).
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1729
Recent Developments:
• In February 2022, The Janssen Pharmaceutical Companies of Johnson & Johnson obtained the United States Food and Drug Administration (FDA) approval for CARVYKTI (ciltacabtagene autoleucel; cilia-cel). This drug is used to treat adults with refractory or relapsed multiple myeloma (RRMM), including an a proteasome inhibitor, immunomodulatory agent, and an anti-CD38 monoclonal antibody.
Segmentation of Biologics Market-
By Source
• Microbial
• Mammalian
• Others
By Product
• MABs
• Vaccines
• Hormones
• Therapeutic Enzymes
• Recombinant Proteins
• Antisense, RNAi & Molecular Therapy
• Blood Factors and Anticoagulants
• Allergenic extracts
• Human Cells and Tissues
• Proteins
• Gene Therapies
• Cellular Therapies
• Others
By Disease
• Oncology
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others
By Manufacturing
• Outsourced
• In-house
By Route of Administration
• Oral
• Others (IV and IP)
By Drug Classification
• Branded Drugs
• Generic Drugs
By Mode of Purchase
• Prescription Drugs
• Over-The-Counter (OTC) Drugs
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
View Overview Report: https://www.insightaceanalytic.com/report/biologics-market/1729
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biologics Market Outlook Highlighting Key Trends in Oncology Immunological and Cardiovascular Applications Through 2031 here
News-ID: 3975091 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
RNAi Pesticides Market Report on the Untapped Growth Opportunities in the Indust …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "RNAi Pesticides Market"-, By Application (Insect Pest Control, Weed Management, Disease Management, Resistance Management), By Crop Type (Agricultural Application, Non-Agricultural Application), By Product (Tropical RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others), By Formulation (Liquid Formulation, Granular Formulation, Powder Formulation, Others), Industry Trends, and Global Forecasts, 2025-2034 And Segment Revenue and Forecast To 2034."
The RNAi…
Rice Bran Wax Lubricant Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rice Bran Wax Lubricant Market - (By Grade (Food Grade, Industrial Grade, Pharmaceutical Grade), End-use (Automotive, Food and Beverage, Cosmetics and Personal Care, Pharmaceuticals, Chemicals, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Rice Bran Wax Lubricant Market is valued at US$ 394.6 million…
Returnable Plastic Crate Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Returnable Plastic Crate Market - (By Capacity (Less than 10 kg, 10 kg to 20 kg, 21 to 35 kg, 36 to 50 kg, Above 50 kg), By Product Type (Stackable, Nestable, Collapsible), By Material (High-Density Polyethylene (HDPE), Polypropylene (P.P.), Others), By Application (Agriculture, Grocery, Dairy, Bakery, Seafood & Meat, Others)), Trends, Industry Competition…
Respiratory Disease Genetic Testing Market Exclusive Report on the Latest Revenu …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Respiratory Disease Genetic Testing Market- (By Offerings (Products (Kits and Consumables), Services, Others), By Disease Type (COPD (Alpha-1-antitrypsin (AAT), Cystic Fibrosis (CF), Diffuse Lung Disease/Surfactant Dysfunction (RHD (Respiratory Distress Syndrome), PPHN (Persistent Pulmonary Hypertension of the Newborn)), Interstitial lung disease, Pulmonary Arterial Hypertension, Pulmonary Hypoplasia, Primary Ciliary Dyskinesia, Other Diseases (BPD)), By Offerings (PCR, NGS…
More Releases for Biologic
Key Factor Supporting Global Biologic Imaging Reagents Market Development in 202 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Biologic Imaging Reagents Market Size By 2025?
The market relating to biologic imaging reagents has experienced robust expansion recently, projecting an increase from its 2024 valuation of $18.41 billion to $20.1 billion by 2025, reflecting a compound annual growth rate (CAGR) of 9.1%. This upward…
Key Influencer in the Biologic Imaging Reagents Market 2025: Chronic Disease Pre …
How Are the key drivers contributing to the expansion of the biologic imaging reagents market?
As the prevalence of chronic diseases continues to rise, it is anticipated that the biologic imaging reagents market will enjoy substantial growth. Chronic diseases are those that persist for at least a year and necessitate sustained medical attention, often worsening over time. Biologic imaging reagents facilitate the visualisation of organs and affected structures, making it possible…
Key Trends Shaping the Future Biologic Imaging Reagents Market From 2025-2034: I …
What Is the Estimated Market Size and Growth Rate for the Biologic Imaging Reagents Market?
The biologic imaging reagents market has grown at a fast pace in recent years. It is set to expand from $18.41 billion in 2024 to $20.26 billion in 2025 at a CAGR of 10.0%. The growth in previous years can be attributed to the rising prevalence of chronic illnesses, increasing R&D investments, a shift towards personalized…
Biologic Response Modifiers Market - Advancing Immunotherapy: Biologic Response …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Biologic Response Modifiers Market.
Biologic Response Modifiers Market: https://www.growthplusreports.com/report/biologic-response-modifiers-market/9134
The Biologic Response Modifiers Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Nerve Biologic Products Market - Advancements in research and development for de …
The report presents an in-depth assessment of the Nerve Biologic Products Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses…
Biologic Microscope Market Global Insights and Demand 2020
Global Biologic Microscope Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters.
This Biologic Microscope Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes…
